Stock screenerAll disclosures →
EDGAR →
GRAL
Conviction 77HealthcareScan · Thu, Jun 25, 2026GRAL$66.42+2.85%
ResistanceSupportVol 14Insider sell3
Vol MA14 732.43K
Mar 26Apr 14May 1May 19Jun 8Jun 25
Price66.42
Change+2.85%
Gap+0.37%
Rel volume2.30×
Avg volume942.87K
Avg $ vol60.13M
SMA 2062.70
SMA 5059.92
SMA 20072.02
Price vs 50+10.84%
Price vs 200-7.77%
MA stackmixed
50/200 cross—
Supertrenddown · 73.00
RSI (14)58
MACD hist0.24
MACD crossbull · 0d
Stoch %K / %D83 / 61
ADX (14)17
+DI / −DI29 / 16
RSI divergence—
MACD divergence—
ATR %+6.80%
ADR %7.64%
52w high116.06
52w low31.42
From 52w high-42.77%
Above 52w low+111.39%
New 52w highNo
SqueezeOff
Bollinger width26.21%
%B0.73
Donchian pos47.64%
Donchian high79.50
Donchian low54.52
AVWAP (52w high)61.28
vs AVWAP high+8.38%
AVWAP (52w low)68.95
vs AVWAP low-3.66%
OBV trendFlat
Chaikin MF (20)0.06
Today vs 20d2.30×
Avg vol (14d)732.43K
Avg vol (20d)942.87K
Avg $ vol (20d)60.13M
Market cap2.85B
RS 3m (vs SPY)+20.49%
RS 6m (vs SPY)-36.84%
RS line new highNo
Trend template5/8
Technical rank36.7
1 week+11.72%
1 month-3.68%
3 months+27.02%
6 months-29.60%
1 year+51.13%
YTD-25.26%
P/E-6.98
P/B1.14
P/S19.37
P/FCF-9.50
EPS-11.11
Div yield—
ROE-16.33%
ROA-14.57%
Debt/Eq—
Current11.74
EV/EBITDA—
Gross margin—
Net margin-277.47%
Rev growth17.18%
EPS growth79.85%
Price target65.57
Target upside-1.28%
Analyst ratingHold
Institutional86.66%
Ent. value2.78B
Revenue40.78M
Net income-93.19M
Gross profit—
Free cash flow-299.92M
IndustrySERVICES-MEDICAL LABORATORIES
ExchangeNasdaq
Shares out42.92M
Employees910
ListedWed, Jun 12, 2024
Free float34.82M
Float %89.3%
Short interest6.36M
Days to cover8.8d
Short volume71.5%
Squeeze score97 / 100
Next earnings—
EPS forecast—
Last EPS vs est−$2.29 vs −$3.00
Last surprise+23.7% beat
Setup gradeA
Conviction77 / 100
Pattern quality—
Tech rank36.7 / 100
Group rank50 / 100
Status laneNo active setup
Setup direction—
Pattern family
Resistance74.22
Support53.77
Days since event—
Candle confirm—
News sentiment—
Financials as of Tue, Mar 31, 2026 · quarterly.
Congress activity
Disclosed STOCK Act trades in GRAL
No recent disclosed trades by Congress in GRAL. STOCK Act filings can lag the trade by up to 45 days.
Insider activity
SEC Form 4 transactions in GRAL · 9 buys · 1 sell
| Insider | Side | Shares | Value | Traded | Filed |
|---|---|---|---|---|---|
Krevans Sarah Director · Common Stock · 2026-06-18 | Grant | 5.49K | $350K | 2026-06-18 | 2026-06-22 |
CHASE WILLIAM J Director · Common Stock · 2026-06-18 | Grant | 5.49K | $350K | 2026-06-18 | 2026-06-22 |
SUMME GREGORY L Director · Common Stock · 2026-06-18 | Grant | 5.49K | $350K | 2026-06-18 | 2026-06-22 |
MIZELL STEVEN Director · Common Stock · 2026-06-18 | Grant | 5.49K | $350K | 2026-06-18 | 2026-06-22 |
Partridge Andrew John Chief Growth Officer · Common Stock · 2026-06-04 | Sell | 1.49K | $91K | 2026-06-04 | 2026-06-05 |
Ofman Joshua J. Chief Executive Officer · Common Stock · 2026-06-03 | Grant | 3.15K | $193K | 2026-06-03 | 2026-06-03 |
Ofman Joshua J. Chief Executive Officer · Common Stock · 2026-06-01 | Grant | 27.9K | $1.8M | 2026-06-01 | 2026-06-03 |
CHASE WILLIAM J Director · Common Stock · 2026-04-15 | Grant | 408 | $20K | 2026-04-15 | 2026-04-17 |
MIZELL STEVEN Director · Common Stock · 2026-04-15 | Grant | 396 | $20K | 2026-04-15 | 2026-04-17 |
SUMME GREGORY L Director · Common Stock · 2026-04-15 | Grant | 631 | $31K | 2026-04-15 | 2026-04-17 |
SEC filings
EDGAR filings in GRAL · 3 recent
Get daily signals & real-time alerts.
StockSetups scans ~12,300 US stocks & ETFs after every close and sorts every long setup into four ranked lanes — each with a trade plan — plus an always-on engine firing 35+ real-time intraday alerts. Free for 7 days, cancel in one click.
Start free — 7-day full access →Educational data, not financial advice. Patterns, levels and the trade plan are algorithmic, not a recommendation to trade.